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SUMMARy – Well-differentiated cancers, both papillary and follicular, account for 90% of all 
diagnosed thyroid cancers. They have an indolent disease course with a 20-year disease-specific sur-
vival over 90%. According to current guidelines, the therapy of choice for well-differentiated thyroid 
carcinoma is total thyroidectomy or lobectomy. The indication for prophylactic central neck dissection 
is still a controversial issue and the subject of unfinished and ongoing debate. There is no indication 
for prophylactic central neck dissection in follicular thyroid carcinomas, which primarily metastasize 
hematogenously. in small solitary papillary thyroid carcinomas (t1 and t2), prophylactic central neck 
dissection is not indicated as it does not bring benefits in terms of improved patient survival and at the 
same time significantly increases the risk of temporary and permanent postoperative complications. 
Prophylactic central neck dissection is indicated in advanced papillary thyroid cancers (t3 and t4) 
and all other high-risk well-differentiated thyroid cancer, as well as in the presence of metastatic 
lymph nodes in the lateral neck.
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Introduction
According to 2018 statistical reports, thyroid can-
cer is the 11th most common human cancer, with ap-
proximately 570,000 new cases per year1. Compared to 
statistics from ten years ago, there has been a world-
wide increase in the incidence of over 100%2. This in-
crease is probably not only in relation to the increased 
exposure of the population to known risk factors for 
the development of thyroid cancer but rather also due 
to the easy and widespread availability of diagnostic 
technologies, especially ultrasound3.
The peak incidence of thyroid cancer is at between 
45 and 55 years of age4, with an overall incidence ratio 
of 4:1 in favor of women2. overall, the five-year sur-
vival rate for thyroid cancer is excellent, at over 95%, 
making it one of the best-treatable cancers. The mor-
tality rate is only 0.5 deaths per 100,000 and has not 
changed significantly over the last 40 years5.
Well-differentiated cancers, both papillary and 
 follicular, account for 90% of all diagnosed thyroid 
cancers. They have an indolent disease course, with a 
20-year disease-specific survival of over 90%6,7.
According to current guidelines, the therapy of 
choice in most patients who have cytologically veri-
fied, well-differentiated thyroid cancer (papillary or 
follicular) is total thyroidectomy8,9. With that ap-
proach, surgery eliminates any possibility of residual 
multifocal disease and allows the use of radioactive 
K. Gršić et al. Prophylactic central neck dissection in well-differentiated thyroid cancer
88 Acta Clin Croat, Vol. 59, (Suppl. 1) 2020
iodine for diagnostic and therapeutic purposes10. Se-
rum thyroglobulin remains useful in follow-up of the 
disease and can be valuable for early detection of tu-
mor recurrence. in solitary thyroid carcinomas up to 1 
cm in diameter, it is enough to only perform a lobec-
tomy of the affected thyroid lobe. in such cases, the 
contralateral lobe of the thyroid gland must have a 
regular echographic appearance, the cancer must not 
have extrathyroidal spread, and there should be no 
positive regional lymph nodes11,12. Such an approach 
for low-risk cancers is a favorable treatment for many 
patients today, with no adverse effect on overall sur-
vival13. Dissection of the central (levels Vi and Vii) 
and lateral regions of the neck (levels ii to V) is indi-
cated if there is cytologically verified existence of met-
astatic lymph nodes12. The performance of prophylac-
tic central neck dissection is still a controversial issue 
and the subject of ongoing debate.
Clinical anatomy and extent  
of comprehensive central neck dissection
Central neck compartment is composed of level Vi 
and the upper part of level Vii (figure 1). level Vi is 
cranially bounded by the hyoid bone, caudally bound-
ed by the upper margin of the sternum, and laterally 
with both common carotid arteries. The superficial 
layer of deep cervical fascia represents the anterior 
border (posterior margin of the sternothyroid muscle), 
while a deep layer of the deep cervical fascia (preverte-
bral fascia) forms the posterior border. level Vi ex-
tends caudally to level Vii, where the origin of the 
right brachiocephalic artery forms the lower edge. The 
nodes of the central neck area are divided into four 
groups: prelaryngeal (Delphian), pretracheal, left para-
tracheal, and right paratracheal lymph nodes (figure 
2). Prelaryngeal and pretracheal lymph nodes and 
lymph nodes of at least of one paratracheal region – 
left or right – are always removed when performing 
central neck dissection. if both paratracheal regions 
are included, central neck dissection is considered to 
be bilateral14.
Therapeutic central neck dissection (rCnD) is per-
formed in all patients with clinically positive meta-
static lymph nodes (cn+). Metastases are usually de-
tected by clinical preoperative cytological examination 
or intraoperative frozen section biopsy. Prophylactic 
central neck dissection (pCnD) removes all nodes in 
level Vi and Vii, although preoperative diagnostics 
may find no suspected lymph nodes (cn0). The extrac-
tion of the affected metastatic lymph nodes alone, i.e. 
keeping all others intact (berry picking), should be 
avoided since the possibility of metastatic recurrence 
in the neck after such surgery is approximately ×10 
higher than after complete compartment dissection15.
Figure 1. Lymph nodes in the neck are grouped into levels 
I-V. The central neck compartment is composed of level VI 
and the upper part of level VII.
Figure 2. The nodes of the central neck area are divided 
into four groups: prelaryngeal, pretracheal, left 
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technically, the most challenging part of central 
neck dissection is resection of paratracheal nodes due 
to necessity of preserving of all crucial structures in 
this region, such as the recurrent laryngeal nerve, para-
thyroid glands, and their vascular supply.
The clinical and anatomical features of the right 
and left paratracheal regions are significantly different 
(figure 3). They are determined by the relationship be-
tween the recurrent laryngeal nerve and the subclavian 
artery on the right and the aortic arch on the left side. 
in the right paratracheal space, the recurrent nerve has 
an oblique direction from caudal to cranial, passing 
from lateral to medial. Depending on the relationship 
of the right subclavian artery to the trachea, and com-
pared with the contralateral nerve, the right recurrent 
laryngeal nerve runs more ventrally through the para-
tracheal space, dividing the lymph nodes of this com-
partment into the anterior and posterior groups16. 
During dissection, special attention should be afforded 
to the posterior region, which often contains a large 
number of positive nodes, and is, therefore, the site of 
recurrence after incomplete dissections17. The left re-
current laryngeal nerve has a much simpler course. its 
position is constantly dorsal and follows a groove be-
tween the trachea and esophagus in a parallel manner. 
Accordingly, all lymph nodes in the left paratracheal 
region are in front of the recurrent laryngeal nerve16.
Good knowledge of the clinical anatomy and pos-
sible variations of the recurrent laryngeal nerve, along 
with fine surgical technique, is essential for its preser-
vation and reduction of postoperative complications18. 
Based on cadaveric studies and intraoperative observa-
tions, more than one nerve branch has been found in 
39 to 73% of patients19,20. in 89% of the cases, nerve 
branching occurs superior to the intersection of the 
recurrent laryngeal nerve and inferior thyroid artery. 
The damage of the most anterior branch of the recur-
rent laryngeal nerve, which almost exclusively carries 
motor fibers, leads to laryngeal musculature paresis21. 
The posterior branch is mainly sensory and carries mo-
tor fibers in only 8% of patients22. injury to these will 
not have substantial consequences, but patients may 
have significant dysphagic difficulties. According to 
numerous authors, the pattern of extralaryngeal 
branching of the recurrent laryngeal nerve directly 
correlates with the incidence of postoperative paraly-
sis23,24.
While performing a paratracheal dissection, it is a 
surgical challenge to preserve the parathyroid glands 
and their vascularization. This is especially difficult for 
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the inferior parathyroid gland, which in almost 90% of 
cases receives vascularization from the inferior thyroid 
artery, which passes beneath the area that should be 
dissected from all suspected lymph nodes. The upper 
parathyroid gland is somewhat easier to preserve dur-
ing paratracheal neck dissection, especially in situa-
tions where it receives circulation exclusively from the 
superior thyroid artery. however, this anatomical vari-
ation is present in only 15% of patients25. if the para-
thyroid gland does not appear viable at the end of the 
surgery, it is advisable to perform an intraoperative 
frozen section biopsy to verify the tissue of the para-
thyroid gland. Then the parathyroid gland tissue needs 
to be shredded into small pieces and implanted into 
the ipsilateral sternocleidomastoid muscle.
Preoperative evaluation of central neck
Proper preoperative diagnostics are a prerequisite 
for a successful surgical plan and execution. for well-
differentiated thyroid carcinomas, it is necessary to 
evaluate all lymph nodes of the lateral and central neck 
region, as well as perform an additional examination of 
the central neck region intraoperatively. The basis of 
preoperative diagnostics is a high-resolution ultra-
sound scan and fine-needle aspiration (fnA) of all 
suspected nodes and their cytological evaluation26. The 
determination of thyroglobulin in aspirates of the sus-
picious nodes significantly increases the sensitivity of 
the entire process. The sensitivity and specificity in de-
tecting lateral side metastases are several times higher 
than in the central region of the neck; sensitivity is 
93.8% in the lateral neck compared with 30% in the 
central neck27. This significant difference is due to the 
complex anatomy of the central region of the neck. The 
lymph nodes of the central region are smaller in diam-
eter, located in a groove between the thyroid, trachea, 
and esophagus. The air in the trachea creating artefacts 
represents a particular problem which makes ultra-
sound even more challenging. The interpretation of 
the ultrasound findings is highly dependent on the ex-
perience of the physician performing the examination. 
The presence of lymphocytic thyroiditis, which is al-
most regularly accompanied by inflammatory lymph-
adenopathy, may further complicate the interpretation 
of the central neck lymph nodes status28.
if there is a suspicion of extrathyroidal cancer spread 
with infiltration of the larynx, esophagus, trachea, and 
the main blood vessel in the neck, or if there is a possi-
bility of the existence of mediastinal and retropharyn-
geal lymph nodes, a Ct of the head and neck and tho-
rax should be used. The use of iodine contrast when 
performing Ct facilitates in displaying vital structures 
but delays the possible administration of radioactive io-
dine postoperatively. MR of the head and neck may be 
an alternative to Ct; however, in the central neck re-
gion, it is far less informal compared with Ct.
Indication for elective central neck dissection
it is rational to perform therapeutic central neck 
dissection (rCnD) in patients with well-differentiated 
thyroid cancer in whom central neck metastases are 
preoperatively confirmed. The presence of positive 
lymph nodes and previously performed ipsilateral 
rCnD is not an indication for contralateral pCnD 
but requires careful additional intraoperative evalua-
tion of the opposite paratracheal region. The prophy-
lactic dissection of the central neck (pCnD) in well-
differentiated cancers is still the subject of debate.
Proponents of pCnD believe that elective central 
neck dissection results precise information about the 
stage of the disease. That information is essential in the 
planning of the intensity of postoperative radioiodine 
ablation. When performing pCnD, a possible second 
surgery for residual metastatic lymph nodes can be 
avoided. Until now, no randomized controlled trials 
have been conducted to provide a precise answer to the 
rationale for performing such surgery.
follicular carcinomas metastasize primary hema-
togenously and only occasionally lymphogenously to 
regional lymph nodes of the neck29. Positive neck 
lymph nodes are found in less than 5% of patients. The 
most common locations for distant metastases are the 
lungs and brain30, found in between 6 to 20% of pa-
tients31,32. There is generally no indication for pCnD 
in follicular cancers, except in those with clinically 
verified central neck metastases.
Papillary thyroid carcinomas are characterized by 
metastases through the lymphatic pathways, predomi-
nantly into regional lymph nodes. They most often 
metastasize to the lymph nodes in level Vi (paratra-
cheal)33 and later into the lateral part of the neck, 
mostly in level iii and iV, and extremely rarely in level 
i34. Skip metastases to the lateral neck, in the absence 
of central neck metastases, are found in a total of 20% 
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of cases35. They are associated primarily with cancers of 
the upper third of the thyroid gland and mainly metas-
tasize to level ii and iii of the neck36-38. 83% of the 
patients who have positive lateral neck nodes also have 
microscopic metastases in the ipsilateral central region 
that have not been verified by any preoperative diag-
nostic procedure39. in these patients, there is an indica-
tion for ipsilateral pCnD regardless of the negative 
clinical status of the central lymph nodes.
At the time of diagnosis of papillary thyroid carci-
noma, 5-10% of patients will have clinically evident 
palpatory regional metastatic disease. This percentage 
can reach up to 30% of patients with the introduction 
of modern diagnostic devices such a high-resolution 
ultrasound with fine-needle aspiration biopsy, Ct, or 
MR40-43. That kind of metastatic disease is defined as 
macroscopic disease.
Standard histopathological techniques (hematoxy-
lin and eosin stain) typically reveal positive lymph 
nodes in 30 to 50% of patients undergoing an elective 
central and lateral neck dissection for papillary thyroid 
cancer12,44. After an additional immunohistochemical 
evaluation (i.e. cytokeratin stain) on the same surgical 
specimen, microscopic metastases were detected in up 
to 90% of patients33,45,46. This supports the theory that 
most patients with papillary thyroid cancer at the time 
of diagnosis have disseminated microscopic disease, 
which in most cases does not become clinically evi-
dent. it is assumed that most papillary thyroid cancers 
have an indolent clinical course or that levothyroxine 
suppression and/or radioactive iodine ablation could 
control the micro-metastatic nodal disease.
Previous studies have suggested that pCnD has a 
positive effect on patient survival, reducing the proba-
bility of regional recurrence47,48. nodal recurrences of 
the neck are characterized by macroscopic metastases 
with extracapsular spread, by higher lymph node den-
sity (positive/negative nodes) in neck dissection, and 
by the presence of more than five metastatic nodes in 
the dissection specimen49. Metastatic recurrences are 
not expected only when microscopic metastases are 
verified after central neck dissection50. Despite an inci-
dence of central micrometastases between 38 and 80%, 
the probability of local nodal recurrence is below 3.8%, 
whether or not central neck dissection is performed29. 
Most recent studies confirm that pCnD prevents the 
occurrence of regional nodal recurrences with statisti-
cal significance, but does not provide any clear benefit 
in long-term patient survival51-53.
Contrary to previous studies, lundgren et al. (in a 
sample of 5,123 patients) and Zaydfudim et al. (in a 
sample of 33,088 patients) analyzed the metastases of 
patients in the central and lateral neck regions and 
found that presence of regional metastases correlated 
with decreased survival. Risk factors were age of more 
than 45 years in papillary cancers, male sex, metastases 
larger than 3 cm with extracapsular spread, and the 
pathohistological finding of widely invasive follicular 
cancer29,54,55.
even if preoperative diagnostics of the central re-
gion of the neck have not verified metastatic nodes, 
this does not preclude the surgeon from sending suspi-
cious nodes based on intraoperative clinical finding to 
intraoperative frozen-section histological analysis. 
Depending on the findings of the frozen-section bi-
opsy, a conversion toward rCnD can be done. Some 
authors affirm that the sensitivity and specificity of in-
traoperative frozen-section biopsy are up to 100%56. 
however, even an experienced surgeon recognizes only 
26% of the actual metastases based on the intraopera-
tive appearance of the lymph node57.
According to current scientific knowledge, there is 
no indication for performing an ipsilateral pCnD in 
smaller solitary (t1 and t2) thyroid cancers. The pre-
disposing factors for the development of regionally 
metastatic disease are thyroid carcinomas of larger di-
ameter (t3 and t4), multicenter carcinomas, carcino-
ma of the younger population, an aggressive subtype of 
carcinomas (tall cell, diffuse sclerotic, and insular) and 
the presence of BRAf mutations in the tumor ge-
nome58-62. in such cancers, the performance of ipsilat-
eral pCnD is indicated. however, most of the data 
about thyroid cancer malignant potential are available 
postoperatively, after an accurate histopathological 
analysis of the tumor. That kind of information cannot 
be used in an anterograde fashion in the planning of 
the extent of surgery and eventually performing 
pCnD.
Morbidity in elective central neck dissection
Most authors agree that there is no significantly 
difference in overall survival between those with clini-
cally negative necks in whom the elective central neck 
dissection is performed and those cured by compre-
hensive central dissection because of a clinically posi-
tive central neck51-53,63. in such circumstances, other 
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issues become important, i.e. potential intraoperative 
and postoperative morbidity. The question is whether 
the benefits of surgery exceed the potential damage 
which neck dissection potentially carries.
Based on seventeen studies involving 1,929 pa-
tients, numerous complications are possible after cen-
tral neck dissection: transient hypocalcemia in 3.6 to 
60.0% of cases, permanent hypocalcemia in 0.0 to 
14.4% of patients, temporary paresis of one vocal cord 
in 0.0 to 25.0% of cases, and permanent paralysis of 
the vocal cords in 0.0 to 11.5% of patients64.
Most authors have demonstrated that the percent-
age of complications – paresis and paralysis of the vo-
cal cords and mainly temporary and permanent hypo-
calcemia – increases when central neck dissection is 
performed after total thyroidectomy65-68. furthermore, 
a study on 103 patients revealed that bilateral central 
dissection carries more complications than a unilateral 
one, especially considering temporary and permanent 
hypoparathyroidism69. however, a study on 1,132 pa-
tients contradicted this claim, finding no statistically 
significant increase in the number of post-operative 
adverse events, especially when an experienced sur-
geon performed surgery70. Zhu et al. reached a similar 
conclusion after analyzing nine independent studies 
with a total of 2,298 cases71. The same conclusion was 
reached by Palestini et al. in their study with a total of 
305 patients65.
An experienced surgeon is defined as one who per-
forms over 100 thyroid surgeries each year and works 
in an institution where at least 150 new patients are 
operated on annually72. Gourin et al. showed a signifi-
cant relationship between surgeon volume and surgical 
morbidity. They also demonstrated a favorable trend of 
increased volume share by high-volume surgeons and 
hospitals in the last 20 years. however, despite that, 
most thyroid surgeries are still not performed by high-
volume providers73. only prospective randomized 
studies in highly specialized thyroid surgery centers 
could give us an answer on the clinical benefit of elec-
tive neck dissections in well-differentiated thyroid car-
cinomas.
Conclusion
Comprehensive central neck dissection must be 
performed in well-differentiated thyroid cancers with 
positive central lymph nodes. According to current 
guidelines, in follicular thyroid carcinomas, which pri-
marily metastasize hematogenously, there is no indica-
tion for prophylactic central neck dissection. in small 
solitary papillary carcinomas (t1 and t2 tumor), pro-
phylactic central neck dissection is not indicated, as it 
does not bring benefits in terms of improved patient 
survival, while at the same time significantly increases 
the risk of temporary and permanent postoperative 
complications like paresis and paralysis of the recur-
rent laryngeal nerve and hypoparathyroidism. Prophy-
lactic central neck dissection is indicated in large pap-
illary thyroid cancers (t3 and t4 tumor), or small 
ones (t1 and t2 tumor) with high-risk factors for 
tumor recurrence and nodal dissemination (extrathy-
roidal spread or presence of BRAf mutation). Meta-
static lymph nodes in the lateral neck, with a regular 
preoperative status of the lymph nodes of the central 
region of the neck, are also an indication for prophy-
lactic central neck dissection.
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Sažetak
inDikACiJe ZA PRofilAktiČkU CentRAlnU DiSekCiJU VRAtA  
koD DoBRo DifeRenCiRAnih kARCinoMA ŠtitnJAČe
Krešimir Gršić, Boris Bumber, Renata Curić Radivojević i Dinko Leović
Papilarni i folikularni karcinomi čine 90% svih zloćudnih tumora štitnjače. Dobro diferencirani karcinomi štitnjače ima-
ju indolentan tijek bolesti, s dvadeset godišnjim za bolest specifičnim preživljenjem preko 90%. totalna tireoidektomija je 
terapija izbora za većinu bolesnika. kod bolesnika s karcinomima niskog rizika moguće je učiniti samo lobektomiju zahva-
ćenog režnja, a da se pritom ne ugrozi ukupno preživljenje bolesnika. Profilaktička disekcija središnjeg dijela vrata predmet 
je brojnih istraživanja zbog nejasnih kliničkih posljedica njezina izvođenja. kod folikularnih karcinoma štitnjače koji primar-
no metastaziraju hematogeno, nema indikacije za profilaktičku disekciju središnjeg vrata. kod malih solitarnih papilarnih 
karcinoma štitnjače (t1 i t2) profilaktička disekcija središnjeg vrata nije indicirana, jer ne donosi koristi u smislu poboljša-
nog preživljavanja pacijenata, a istodobno značajno povećava rizik od privremenih i trajnih postoperativnih komplikacija, 
poput pareza i paralize povratnog laringealnog živca i hipoparatireoidizma. ipsilateralna profilaktička disekcija središnjeg 
vrata indicirana je kod uznapredovalih papilarnih karcinoma štitnjače (t3 i t4) te kod svih ostalih koje karakterizira visok 
rizik za povrat bolesti ili regionalnu diseminaciju. Metastatski limfni čvorovi na lateralnom vratu, s urednim predoperativnim 
statusom limfnih čvorova središnje regije vrata, također su indikacija za profilaktičku disekciju središnjeg vrata.
ključne riječi: dobro diferencirani karcinomi štitnjače, papilarni karcinom štitnjače, folikularni karcinom štitnjače, profilaktička 
disekcija središnjeg vrata, preživljenje
